Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Report 2026
Download Free Sample Buy Now
Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Report 2026

Global Outlook – By Component (Software, Services), By Deployment Mode (Cloud-Based, On-Premises), By Application (Hospitals, Clinics, Research Institutes, Pharmaceutical Companies, Other Applications), By End-User (Healthcare Providers, Life Sciences Companies, Payers, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

• Artificial Intelligence (AI)-Driven Rare Disease Patient Finder market size has reached to $1.62 billion in 2025

• Expected to grow to $5.95 billion in 2030 at a compound annual growth rate (CAGR) of 29.6%

• Growth Driver: Increasing Acceptance Of Digital Health And Telemedicine Is Fueling The Growth Of The Market Due To Rising Patient Demand For Convenient And Accessible Healthcare Solutions

• Market Trend: Technological Advancements Are Driving Faster And More Efficient Patient Identification For Rare Disease Clinical Trials

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market?

An artificial intelligence (AI)-driven rare disease patient finder is a technology platform that leverages AI algorithms to identify and match patients with rare diseases for clinical trials, research studies, and personalized treatments. It analyzes diverse datasets, including medical records, genetic information, and real-world health data, to accurately locate potential patients. By improving patient identification efficiency, it accelerates research, enhances clinical trial recruitment, and supports the development of targeted therapies.

The main components of the artificial intelligence (AI)-driven rare disease patient finder are software and services. Software is a set of programs, instructions, and data that tell a computer or digital device how to perform specific tasks or functions. The various deployment modes are cloud-based and on-premises. The multiple applications involved are hospitals, clinics, research institutes, pharmaceutical companies, and others, and they are used by several end users such as healthcare providers, life sciences companies, payers, and others.

Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Global Report 2026 Market Report bar graph

What Is The Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Size and Share 2026?

The artificial intelligence (ai)-driven rare disease patient finder market size has grown exponentially in recent years. It will grow from $1.62 billion in 2025 to $2.11 billion in 2026 at a compound annual growth rate (CAGR) of 29.9%. The growth in the historic period can be attributed to increasing availability of electronic health records, early adoption of data analytics in clinical research, expansion of genomic databases, rising focus on orphan diseases, initial use of ai in trial recruitment.

What Is The Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Growth Forecast?

The artificial intelligence (ai)-driven rare disease patient finder market size is expected to see exponential growth in the next few years. It will grow to $5.95 billion in 2030 at a compound annual growth rate (CAGR) of 29.6%. The growth in the forecast period can be attributed to increasing investments in precision medicine research, rising demand for faster clinical trial enrollment, expansion of real-world evidence analytics, growing collaboration between healthcare and life sciences firms, increasing regulatory support for rare disease innovation. Major trends in the forecast period include increasing use of AI-based patient identification algorithms, rising integration of multi-source health data, growing automation of clinical trial recruitment, expansion of precision patient matching platforms, enhanced focus on rare disease research enablement.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Segmentation

1) By Component: Software, Services

2) By Deployment Mode: Cloud-Based, On-Premises

3) By Application: Hospitals, Clinics, Research Institutes, Pharmaceutical Companies, Other Applications

4) By End-User: Healthcare Providers, Life Sciences Companies, Payers, Other End-Users

Subsegments:

1) By Software: Electronic Data Capture, Data Management Platform, Analytics And Reporting Tools, Patient Engagement Tools, Clinical Trial Management System

2) By Services: Implementation And Integration, Training And Support, Data Hosting And Security, Consulting Services, Maintenance And Upgrades

What Is The Driver Of The Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market?

The increasing acceptance of digital health and telemedicine is expected to propel the growth of the artificial intelligence (AI)-driven rare disease patient finder market going forward. Digital health is the use of technology, software, and electronic tools to monitor, manage, and improve health and wellness. Telemedicine is the delivery of healthcare services remotely using telecommunications technology, such as video calls, mobile apps, and online platforms. The increasing acceptance of digital health and telemedicine is due to patients and providers seeking convenient, time-saving, and accessible healthcare solutions. Artificial intelligence (AI)-driven rare disease patient finder supports digital health and telemedicine by accurately identifying patients, enabling remote monitoring, timely virtual consultations, and personalized care. For instance, in November 2025, according to the Organisation for Economic Co operation and Development, a France-based intergovernmental organization, reported that OECD countries have made progress in expanding access to EHRs. In 2024, the average availability of online digital health services reached 82%, an increase from 79% in 2023 among countries with comparable data. Therefore, the increasing acceptance of digital health and telemedicine is driving the growth of the artificial intelligence (AI)-driven rare disease patient finder industry.

Key Players In The Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

Major companies operating in the artificial intelligence (AI)-driven rare disease patient finder market are UnitedHealth Group Incorporated, Dassault Systèmes SE, GeneDx Holdings Corp., HealthVerity Inc., ConcertAI Inc., Komodo Health Inc., Unlearn.AI Inc., Antidote Technologies Inc., Healx Ltd., FDNA Inc., Saventic Health Sp. z o.o., Digital Pharma Lab SAS, AnnieGuard Ltd., Rapid Innovation Labs Inc., Sqilline EOOD, TrialX Inc., enGenome Srl, EveryCure Inc., ThinkGenetic Inc., RareSum Inc.

Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Trends and Insights

Major companies operating in the AI-driven rare disease patient finder market are focusing on developing technological advancements, such as precision patient recruitment solutions, to enhance the accuracy, speed, and efficiency of identifying eligible patients for rare disease clinical trials while reducing recruitment timelines and improving trial success rates. A precision patient recruitment solution is a technology-driven approach that uses advanced algorithms and real-world data to accurately identify and engage patients who meet specific clinical trial eligibility criteria. For instance, in April 2024, Citeline, a US-based business intelligence and data analytics company, launched Citeline PatientMatch. The platform combines advanced algorithms with comprehensive real-world data, including lab results, biomarkers, and electronic medical records from over 400 hospitals and health systems, to help sponsors and investigators identify eligible patients for clinical trials in a timely and efficient manner, streamline enrollment, and support diverse and complex study protocols across multiple therapeutic areas.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market?

In September 2025, SeqOne, a France-based provider of AI-powered genomic analysis and clinical decision-support tools, acquired Congenica for an undisclosed amount. With this acquisition, SeqOne aims to integrate its AI-driven next-generation sequencing platform with Congenica’s clinical interpretation technology to enhance rare-disease and oncology diagnostic capabilities, expand global reach, and create a unified software-centric genomics leader. Congenica is a UK-based provider of clinical genomics software services, including scalable genomic data interpretation, clinical variant classification, and rare and inherited disease diagnostic support.

Regional Outlook

North America was the largest region in the artificial intelligence (AI)-driven rare disease patient finder market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market?

The artificial intelligence (AI)-driven rare disease patient finder market consists of revenues earned by entities by providing services such as clinical trial recruitment, patient identification, electronic health record (EHR) data mining, natural language processing (NLP), and real-world evidence (RWE) analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-driven rare disease patient finder market also includes sales of predictive analytics tools, natural language processing engines, machine learning models, data integration platforms, electronic health record connectors, genomic data analyzers, patient matching engines, clinical decision support tools, and real-world data aggregators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Report 2026?

The artificial intelligence (ai)-driven rare disease patient finder market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (ai)-driven rare disease patient finder industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $2.11 billion
Revenue Forecast In 2035 $5.95 billion
Growth Rate CAGR of 29.9% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Component, Deployment Mode, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled UnitedHealth Group Incorporated, Dassault Systèmes SE, GeneDx Holdings Corp., HealthVerity Inc., ConcertAI Inc., Komodo Health Inc., Unlearn.AI Inc., Antidote Technologies Inc., Healx Ltd., FDNA Inc., Saventic Health Sp. z o.o., Digital Pharma Lab SAS, AnnieGuard Ltd., Rapid Innovation Labs Inc., Sqilline EOOD, TrialX Inc., enGenome Srl, EveryCure Inc., ThinkGenetic Inc., RareSum Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Biotechnology, Genomics & Precision Medicine

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Use Of Ai-Based Patient Identification Algorithms

4.2.2 Rising Integration Of Multi-Source Health Data

4.2.3 Growing Automation Of Clinical Trial Recruitment

4.2.4 Expansion Of Precision Patient Matching Platforms

4.2.5 Enhanced Focus On Rare Disease Research Enablement

5. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Analysis Of End Use Industries

5.1 Healthcare Providers

5.2 Life Sciences Companies

5.3 Pharmaceutical Companies

5.4 Research Institutes

5.5 Healthcare Payers

6. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Size, Comparisons And Growth Rate Analysis

7.3. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Segmentation

9.1. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Software, Services

9.2. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cloud-Based, On-Premises

9.3. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Research Institutes, Pharmaceutical Companies, Other Applications

9.4. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Healthcare Providers, Life Sciences Companies, Payers, Other End-Users

9.5. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Electronic Data Capture, Data Management Platform, Analytics And Reporting Tools, Patient Engagement Tools, Clinical Trial Management System

9.6. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Implementation And Integration, Training And Support, Data Hosting And Security, Consulting Services, Maintenance And Upgrades

10. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Regional And Country Analysis

10.1. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

11.1. Asia-Pacific Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

12.1. China Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

13.1. India Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

14.1. Japan Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

15.1. Australia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

16.1. Indonesia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

17.1. South Korea Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

18.1. Taiwan Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

19.1. South East Asia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

20.1. Western Europe Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

21.1. UK Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

22.1. Germany Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

23.1. France Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

24.1. Italy Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

25.1. Spain Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

26.1. Eastern Europe Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

27.1. Russia Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

28.1. North America Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

29.1. USA Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

30.1. Canada Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

31.1. South America Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

32.1. Brazil Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

33.1. Middle East Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

34.1. Africa Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Regulatory and Investment Landscape

36. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Competitive Landscape And Company Profiles

36.1. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Company Profiles

36.3.1. UnitedHealth Group Incorporated Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Dassault Systèmes SE Overview, Products and Services, Strategy and Financial Analysis

36.3.3. GeneDx Holdings Corp. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. HealthVerity Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. ConcertAI Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Other Major And Innovative Companies

Komodo Health Inc., Unlearn.AI Inc., Antidote Technologies Inc., Healx Ltd., FDNA Inc., Saventic Health Sp. z o.o., Digital Pharma Lab SAS, AnnieGuard Ltd., Rapid Innovation Labs Inc., Sqilline EOOD, TrialX Inc., enGenome Srl, EveryCure Inc., ThinkGenetic Inc., RareSum Inc.

38. Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market

40. Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market High Potential Countries, Segments and Strategies

40.1 Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market In 2030 - Countries Offering Most New Opportunities

40.2 Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market In 2030 - Segments Offering Most New Opportunities

40.3 Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Overview Of Key Products - Product Examples
  • Table 2: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Supply Chain Analysis
  • Table 4: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Major Raw Material Providers
  • Table 5: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Major Resource Providers
  • Table 6: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Major Manufacturers (Suppliers)
  • Table 7: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Major Distributors And Channel Partners
  • Table 8: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Key Technologies & Future Trends
  • Table 9: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Major Trends
  • Table 10: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Major End Users
  • Table 11: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market - TAM, US$ Billion, 2025
  • Table 15: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market - Company Scoring Matrix
  • Table 97: UnitedHealth Group Incorporated Financial Performance
  • Table 98: Dassault Systèmes SE Financial Performance
  • Table 99: GeneDx Holdings Corp. Financial Performance
  • Table 100: HealthVerity Inc. Financial Performance
  • Table 101: ConcertAI Inc. Financial Performance
  • Table 102: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Competitive Dashboard
  • Table 104: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Size Gain ($ Billion), Segmentation By Component, 2025 – 2030
  • Table 106: Global, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Size Gain ($ Billion), Segmentation By Deployment Mode, 2025 – 2030
  • Table 107: Global, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Supply Chain Analysis
  • Figure 4: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Major Raw Material Providers
  • Figure 5: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Major Resource Providers
  • Figure 6: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Major Distributors And Channel Partners
  • Figure 8: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Key Technologies & Future Trends
  • Figure 9: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Major Trends
  • Figure 10: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Major End Users
  • Figure 11: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market - TAM, US$ Billion, 2025
  • Figure 15: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market - Company Scoring Matrix
  • Figure 97: UnitedHealth Group Incorporated Financial Performance
  • Figure 98: Dassault Systèmes SE Financial Performance
  • Figure 99: GeneDx Holdings Corp. Financial Performance
  • Figure 100: HealthVerity Inc. Financial Performance
  • Figure 101: ConcertAI Inc. Financial Performance
  • Figure 102: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market, Competitive Dashboard
  • Figure 104: Global Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Size Gain ($ Billion), Segmentation By Component, 2025 – 2030
  • Figure 106: Global, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Size Gain ($ Billion), Segmentation By Deployment Mode, 2025 – 2030
  • Figure 107: Global, Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Coxsackievirus Infections Treatment Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Read More About Coxsackievirus Infections Treatment Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Cranial Fixation System Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

Read More About Cranial Fixation System Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

Crow's Feet Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

Read More About Crow's Feet Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Artificial Intelligence in Healthcare Diagnosis Market Report 2026 - Global Outlook – By Component (Software, Services, Hardware), By Diagnosis (Cardiology, Oncology, Pathology, Radiology, Chest And Lung, Neurology, Othe...

AI In Medical Diagnostics Market Report 2026 - Global Outlook – By Component (Software, Services), By Technology (Natural Language Processing, Computer Vision, Machine Learning, Context-Aware Computing, Other Technologie...

Artificial Intelligence (AI) In Clinical Trials Market Report 2026 - Global Outlook – By Offering (Software, Services), By Process (Trial Design, Patient Selection, Site Selection, Patient Monitoring), By Application (On...

Artificial Intelligence In Cancer Diagnostics Market Report 2026 - Global Outlook – By Component (Software Solutions, Hardware, Services), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, B...

Artificial Intelligence (AI) in Precision Medicine Market Report 2026 - Global Outlook – By Component (Hardware, Software, Service), By Technology (Deep Learning, Querying Method, Natural Language Processing, Context Awa...

Artificial Intelligence in Healthcare Market Report 2026 - Global Outlook – By Offering (Hardware, Software, Services), By Algorithm (Deep Learning, Querying Method, Natural Language Processing, Context Aware Processing)...

Artificial Intelligence in Diabetes Management Market Report 2026 - Global Outlook – By Device (Diagnostic Devices, Glucose Monitoring Devices, Insulin Delivery Devices), By Techniques (Case-Based Reasoning, Intelligent ...

AI In Cancer Diagnostics Market Report 2026 - Global Outlook – By Component (Software Solutions, Hardware, Services), By Cancer Type (Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And...

Frequently Asked Questions

The Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Report 2026 market was valued at $1.62 billion in 2025, increased to $2.11 billion in 2026, and is projected to reach $5.95 billion by 2030. request a sample here

The expected CAGR for the Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Report 2026 market during the forecast period 2025–2030 is 29.6%. request a sample here

Major growth driver of the market includes: Increasing Acceptance Of Digital Health And Telemedicine Is Fueling The Growth Of The Market Due To Rising Patient Demand For Convenient And Accessible Healthcare Solutions in the Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Report 2026 market. For further insights on this market, request a sample here

The artificial intelligence (AI)-driven rare disease patient finder market covered in this report is segmented –
1) By Component: Software, Services
2) By Deployment Mode: Cloud-Based, On-Premises
3) By Application: Hospitals, Clinics, Research Institutes, Pharmaceutical Companies, Other Applications
4) By End-User: Healthcare Providers, Life Sciences Companies, Payers, Other End-Users Subsegments:
1) By Software: Electronic Data Capture, Data Management Platform, Analytics And Reporting Tools, Patient Engagement Tools, Clinical Trial Management System
2) By Services: Implementation And Integration, Training And Support, Data Hosting And Security, Consulting Services, Maintenance And Upgrades request a sample here

Major trend in this market includes: Technological Advancements Are Driving Faster And More Efficient Patient Identification For Rare Disease Clinical Trials For further insights on this market, request a sample here.

Major companies operating in the Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Report 2026 market are Major companies operating in the artificial intelligence (AI)-driven rare disease patient finder market are UnitedHealth Group Incorporated, Dassault Systèmes SE, GeneDx Holdings Corp., HealthVerity Inc., ConcertAI Inc., Komodo Health Inc., Unlearn.AI Inc., Antidote Technologies Inc., Healx Ltd., FDNA Inc., Saventic Health Sp. z o.o., Digital Pharma Lab SAS, AnnieGuard Ltd., Rapid Innovation Labs Inc., Sqilline EOOD, TrialX Inc., enGenome Srl, EveryCure Inc., ThinkGenetic Inc., RareSum Inc. request a sample here.

North America was the largest region in the artificial intelligence (AI)-driven rare disease patient finder market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-driven rare disease patient finder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us